Three pharmacologically-defined classes of ionotropic glutamate receptors were originally named according to their agonist selectivity: N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate. The NMDA receptor consists of at least two distinct subunits, NR1 and NR2 1) (Fig. 1A) . Each subunit has three transmembrane domains (M1, M3, and M4) plus a cytoplasm-facing re-entrant membrane loop (M2). The M2 loop region in the NR1 and NR2 subunits is a critical determinant of divalent cation permeability and Mg 2ϩ block. NR1 is a single gene product expressed as eight alternatively spliced mRNAs, and NR2A, NR2B, NR2C and NR2D are distinct gene products. NMDA receptors probably consist of tetrameric subunit assemblies that have different physiological and pharmacological properties depending on the specific NR2 subunit. In the central nervous system, NMDA receptors play critical roles in a variety of neurophysiological phenomena, including neurodevelopment, synaptic plasticity, and excitotoxicity, because of their high permeability to Ca 2ϩ . Neurodegeneration associated with a variety of acute and chronic disorders (e.g., ischemic stroke, Parkinson's disease, Alzheimer's disease and dementia) is due in part to overactivation of NMDA receptors (Fig. 1B) . Inhibitors of NMDA receptors have thus been developed as anticonvulsants and neuroprotective agents.
. Neurodegeneration associated with a variety of acute and chronic disorders (e.g., ischemic stroke, Parkinson's disease, Alzheimer's disease and dementia) is due in part to overactivation of NMDA receptors (Fig. 1B) . Inhibitors of NMDA receptors have thus been developed as anticonvulsants and neuroprotective agents.
Polyamines (putrescine, spermidine and spermine) are ubiquitously present in prokaryotic and eukaryotic cells. In the central nervous system, specific interactions of polyamines with several structurally and functionally distinct types of cation channels have been reported previously. 2) Among these, the most striking are the blockade of some types of K ϩ channels and the modulation of NMDA receptors. Spermine has complex effects on NMDA receptors, including two types of stimulation and one type of voltage-dependent blockade. One of the effects of spermine is "glycineindependent" stimulation, observed in the presence of saturating concentrations of glutamate and glycine. With recombinant NMDA receptors, this type of stimulation is observed only at receptors containing splice variants of NR1 that lack the exon-5 insert, expressed together with the NR2B subunit. 3) Inhibition by extracellular spermine is strongly voltage-dependent, being more pronounced at hyperpolarized -Dependent Neurotoxicity (A) Schematic illustration of the NR1 and NR2B subunits, which contain three transmembrane segments (M1, M3, M4), a re-entrant loop (M2), an extracellular N-terminal domain, an extracellular loop between M3 and M4, an intracellular loop between M1 and M2, and an intracellular C-terminal domain. The glycine and glutamate binding pockets involving residues from the N-terminal domain and from the M3-M4 loop of NR1 and NR2 subunits, respectively. (B) Excitotoxicity is thought to be a major mechanism contributing to neurodegeneration during central nervous system, ischemia, trauma and other neurological disorders. Excitotoxicity is thought to result from an excessive synaptic release of glutamate. Also, it is generally accepted that the NMDA receptor plays a key role in mediating at least certain aspects of glutamate neurotoxicity, possibly owing to their high Ca 2ϩ permeability. When Ca 2ϩ overloaded, such processes including enzymes (e.g., proteases, lipases, endonucleases) and other metabolic machinery directly damage neurons or lead to the formation of toxic reaction products which ultimately cause cell death. than depolarized membrane potentials. Single-channel patchclamp recording has been used to study the mechanism of this effect. Spermine (10-1000 mM) was found to decrease both single-channel conductance and average channel opentime.
We previously reported that N-{4- [4-(4-guanidinobutylamino) butylamino]butyl}-p-toluenesulfonamide trihydrochloride (TsHSPMG) (1a) and N-{3- [4-(3-guanidinopropylamino) butylamino]propyl}-p-toluenesulfonamide trihydrochroride (TsSPMG) (2a) inhibited the activity of NMDA receptors expressed in Xenopus oocytes. Their antagonistic activities were more potent than that of memantine, an NMDA antagonist. TsHSPMG (1a), which has a longer polyamine tail than TsSPMG (2a), showed more potent antagonistic activity. We therefore concluded that the homospermine moiety and guanidyl group play an important role in neuroprotection against NMDA toxicity. 4) Pöhler et al. reported synthesis and pharmacological properties of polyamine derivatives and also exhibited that some analogs of 5-(4-aminobutyl)-2-thiophene-octylamine inhibited NMDA receptor binding using [ 3 H]MK-801 binding assay methods. 5) In this paper, we report the syntheses of TsSPMG (2a) and N-{3- [4-(3-guanidinopropylamino) butylamino]propyl}bu-tane-1-sulfonamide trihydrochroride (BsSPMG) (2b), which have a guanidyl group on the spermine moiety, and TsHSPMG (1a) and N-{4- [4-(4-guanidinobutylamino) butylamino]butyl}butane-1-sulfonamide trihydrochloride (BsH-SPMG) (1b), which have a homospermine moiety instead of spermine. Through the addition of the guanidyl group or homospermine moiety we aimed at construct compounds which are less sensitive to polyamine oxidases (spermine oxidase and acetylpolyamine oxidase) and degrade spermine to produce acrolein, a toxic unsaturated aldehyde. 6 ) TsHSPMG (1a), TsSPMG (2a), BsHSPMG (1b) and BsSPMG (2b) (at concentrations up to 300 mM) were non-toxic to cells in the presence of fetal bovine serum (FBS) (data not shown). Neuronal cell death due to supranormal excitability of NMDA receptors is common under pathological depolarized conditions. The effects of these polyamine derivatives were investigated on NR1/NR2B receptors in the depolarized state in the presence of saturated or unsaturated concentrations of glycine, because spermine stimulates NMDA receptor activity under depolarized conditions. Also, N 4 -benzylspermine and N 4 -(3-phenylpropyl)spermine may stimulate NMDA receptor activities, because the low concentration of these polyamine derivatives promoted quantity of [ 3 H]MK-801 binding to NMDA receptor.
7)

Results and Discussion
The synthesis of polyamine compounds TsHSPMG (1a) and BsHSPMG (1b) is outlined in Chart 1. 4-(4-Methoxybenzyloxycarbonyl)amino-1-butanol (3) was synthesized from 4-methoxybenzyl S-(4,6-dimethylpyrimidin-2-yl)thiocarbonate and 4-amino-1-butanol in CHCl 3 , which was converted to tosylate (4) . Tosylate (4) was condensed with 4-amino-1-butanol in N,N-dimethylformamide (DMF) at 90°C to yield 5. Protection of the amino nitrogen in 5 with a Ntert-butoxycarbonyl (Boc) group, esterifcation of the resulting alcohol (6) as the tosylate, and condensation of the tosylate (7) and 4-amino-1-butanol gave the corresponding primary alcohol (8) . After protecting the amino nitrogen of 8 with N-Boc, the terminal hydroxyl group was mesylated with methanesulfonyl chloride (MsCl) to yield 10. Mesylate 10 was converted to azide compound (11) and subsequent hydrogenation using palladium-activated carbon ethylenediamine complex (Pd-C(en)) gave primary amino compound (12). Compound 13 was obtained by treatment of 12 with N, NЈ-bis(tert-butoxycarbonyl)-S-methylisothiourea in CH 2 Cl 2 . The removal of the 4-methoxybenzyloxycarbonyl group in 13 gave 14, then the terminal amino group in 14 was converted to p-toluenesulfonamide compound 15 and butanesulfonamide compound 16. Finally, the Boc protecting groups of 15 and 16 were cleaved to give the desired compounds TsHSPMG (1a) and BsHSPMG (1b).
The synthesis of polyamine compounds TsSPMG (2a) and BsSPMG (2b) is outlined in Chart 2. Treatment of 4,9-diaza-4,9-di-(tert-butoxycarbonyl)dodecane-1,12-diamine 8) with ptoluenesulfonyl chloride (TsCl) in the presence of triethylamine (TEA) in CH 2 Cl 2 gave p-toluenesulfonamide compound 18 in 49% yield, and then the terminal primary amino group in 18 was converted to guanidino compound (20) by treating 18 with N,NЈ-bis(tert-butoxycarbonyl)-S-methylisothiourea in CH 2 Cl 2 . Finally, the Boc protecting groups of 20 were removed using 36% HCl in tetrahydrofuran (THF) to give the desired compound TsSPMG (2a). BsSPMG (2b) was synthesized from butane-1-sulfonyl chloride (BsCl) by a method similar to that used to synthesize TsSPMG (2a).
The effects of the polymines TsHSPMG (1a), BsHSPMG (1b), TsSPMG (2a), BsSPMG (2b) and spermine on NMDA (NR1A/NR2B) receptors were studied using voltage-clamp recordings of recombinant NR1A/NR2B receptors expressed in Xenopus oocytes. We measured the effects of TsHSPMG (1a), BsHSPMG (1b), TsSPMG (2a), BsSPMG (2b) and spermine (100 mM) on responses to glutamate (10 mM, with 0.1 or 10 mM glycine) by NR1A/NR2B receptors in oocytes voltage-clamped at Ϫ20 mV. Spermine potentiates 153% and 310% of NMDA (NR1A/NR2B) receptors in the presence of saturated or unsaturated glycine, respectively. Spermine potentiates NMDA receptor currents in the presence of saturating concentrations of glycine (10 mM, glycine-independent stimulation), an effects that involves an increase in the frequency of channel opening and decrease in the desensitization of NMDA receptors. A second effect for the potentiation involves an increase in the affinity of NMDA receptors for glycine (0.1 mM, glycine-dependent stimulation). However, all the novel derivatives, TsHSPMG (1a), BsHSPMG (1b), TsSPMG (2a) and BsSPMG (2b) significantly inhibited NR1A/NR2B receptors in both conditions. The inhibition of NMDA receptors by BsSPMG (2b), BsHSPMG (1b), TsSPMG (2a) and TsHSPMG (1a) in the presence of saturated glycine (10 mM) was 26%, 83%, 62% and 82%, respectively. Comparable results were obtained in the presence of unsaturated glycine (0.1 mM) (Fig. 2) . Inhibition by extracellular spermine is strongly voltage-dependent and may be due to fast open-channel block, similar to that by Mg 2ϩ . Synthesized polyamine derivatives had voltage dependent inhibitory effects on NMDA receptor currents, but the facilitatory effects disappeared. NMDA receptor subtypes are thought to play a predominant role in triggering glutamate neurotoxicity in the central nervous system. Thus, polyamine derivatives may have neuroprotective effects towards glutamate neurotoxicity. Further pharmacological data regarding BsHSPMG and BsSPMG will be described elsewhere.
Experimental
Melting points were determined using a Yanagimoto Yanaco MP melting point apparatus and are uncorrected. H-NMR (500 MHz) and 13 C-NMR (125 MHz) spectra were recorded on a JEOL JNM-ECA 600 spectrometer using tetramethylsilane as a standard. Mass spectra (MS) were measured on a JEOL LMS-GC mate instrument. IR spectra were recorded on a JASCO FT/IR300E spectrometer. Adult female Xenopus laevis were chilled on ice,
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Fig. 2. Effects of Spermine (SPM) and Polyamine Derivatives on NR1/ NR2B Receptors at Ϫ20 mV
Representative traces showing the effects of 100 mM spermine or TsHSPMG (1a) on the NR1/NR2B receptors. The effects of 100 mM spermine, TsHSPMG (1a), BsHSPMG (1b), TsSPMG (2a) and BsSPMG (2b) were determined in oocytes expressing NR1/NR2B receptors. Currents were evoked using 10 mM glutamate with 0.1 or 10 mM glycine and voltage-clamped at Ϫ20 mV. Macroscopic currents in the presence of spermine or polyamine derivatives were expressed as a percentage of the control response at the NMDA receptors. Data represent the meanϮS.E.M. from 4 or 5 oocytes. and the preparation and maintenance of oocytes were performed as described previously. 9) Capped cRNA was prepared from linearized cDNA templates using mMessage mMachine kits (Ambion, Austin, TX, U.S.A.). Oocytes were injected with NR1A and NR2B cRNAs at a ratio of 1 : 5 (0.2-1 ng of NR1A plus 1-5 ng of NR2B). Macroscopic currents were recorded with a two-electrode voltage-clamp using Dual Electrode Voltage Clamp Amplifier CEZ-1250 (Nihon Koden, Tokyo, Japan). Electrodes were filled with 3 M KCl. Oocytes were continuously superfused (ca. 5 ml/min) with a Mg 2ϩ -free saline solution (96 mM NaCl, 2 mM KCl, 1.8 mM BaCl 2 , 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5). This solution contained BaCl 2 rather than CaCl 2 , and in all experiments, oocytes were injected with K ϩ -1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-bis-tetraacetic acid (BAPTA; Sigma, St. Louis, MO, U.S.A.; 100 nl of 40 mM solution at pH 7.5) on the day of recording to eliminate Ca 2ϩ -activated Cl-currents. Glutamate and glycine were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
4-(4-Methoxybenzyloxycarbonyl)amino-1-butanol (3)
A mixture of 4-amino-1-butanol (2.67 g, 30 mmol) and p-methoxybenzyl S-(4,6-dimethylpyrimidin-2-yl)thiocarbonate (9.12 g, 30 mmol) in CHCl 3 (160 ml) was stirred at room temperature overnight. The reaction mixture was washed successively with 4% aqueous NaHCO 3 
4-(4-Methoxybenzyloxycarbonyl)aminobutyl-1-p-toluenesulfonate (4)
To a solution of 3 (7.24 g, 28.58 mmol) and TEA (12 ml, 85.7 mmol) in CH 2 Cl 2 (150 ml), TsCl (5.43 g, 28.58 mmol) was added at 0-5°C. The reaction mixture was stirred for 5 h at 0-5°C and then at room temperature overnight. The mixture was washed with brine, dried over MgSO 4 , and concentrated under reduced pressure. The residue was chromatographed on a silica gel column. Elution with EtOAc : hexane (1 : 1) afforded a colorless oil (9.28 g, 80% 10-(4-Methoxybenzyloxycarbonyl)-5,10-diaza-1-decanol (5) A solution of 4 (9.28 g, 22.8 mmol) and 4-amino-1-butanol (82.59 g, 29 mmol) in DMF (14 ml) was stirred at 90°C for 2.5 h. The reaction mixture was poured into ice water. The solution was made alkaline (pH 12) by adding 5% aqueous KOH solution and extracted with CH 2 Cl 2 . The organic layer was washed with brine and dried over Na 2 SO 4 , and then the solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel with CHCl 3 : MeOH : 25% NH 4 OHϭ100 : 10 : 1) to give a colorless oil (4.43 g, 60% 5-tert-Butoxycarbonyl-10-(4-methoxybenzyloxycarbonyl)-5,10-diazadecyl p-Toluenesulfonate (7) To a solution of 6 (6.14 g, 13.75 mmol) and TEA (6.1 ml, 43.57 mmol) in CH 2 Cl 2 (150 ml), TsCl (2.75 g, 14.42 mmol) was added at 0-5°C. The reaction mixture was stirred for 5 h at 0-5°C and then at room temperature overnight. The mixture was washed with brine, dried over MgSO 4 , and then concentrated under reduced pressure. The residue was chromatographed on a silica gel column. Elution with EtOAc : hexane (1 : 1) afforded a colorless oil (4.85 g, 61% 5,10-Di-tert-butoxycarbonyl-15-(4-methoxybenzyloxycarbonyl)-5,10,15-triazapentadecylamime (12) A solution of 11 (3.9 g, 6.28 mmol) in THF (36 ml) was hydrogenated over 3.5-6.5% palladium-activated carbon ethylenediamine complex (Pd-C(en)) (0.65 g) at room temperature for 2 h under H 2 atmosphere. The catalyst was filtered through a pad of celite, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography on silica gel with CHCl 3 : MeOH : 25% NH 4 OH (100 : 20 : 2) to give a colorless oil (3.14 g, 84% 6H, br s), 1.49 (9H, s), 1.50 (9H, s), 3.16-3.22 (10H, m), 3.40-3.45  (2H, m), 3.80 (3H, s), 5.02 (2H, s), 6.88 (2H, d, Jϭ8 .58 Hz), 7.29 (2H, d,
Jϭ8.58 Hz).
{4-[(4-Aminobutyl)-tert-butoxycarbonylamino]butyl}-{4-[N,N؆-bis-(tert-butoxycarbonyl)guanidinobutyl]}carbamic Acid tert-Butyl Ester (14)
A solution of 13 (220 mg, 0.145 mmol) in THF (4 ml) was hydrogenated over 10% Pd-C (60 mg) at room temperature for 2 d under H 2 atmosphere. The catalyst was filtered through a pad of celite, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography on silica gel with CHCl 3 : MeOH : 25% NH 4 OH (100 : 10 : 1) to give a colorless oil (80 mg, 49% 59 (48H, m), 3.16 (10H, br s), 3.41-3.22 (2H, m) . 4,9-Di-tert-butoxycarbonyl-13-(p-toluenesulfonyl)-4,9,13-triazatridecylamime (18) 4,9-Diaza-4,9-di-(tert-butoxycarbonyl)dodecane-1,12-diamine (17) (201 mg, 0.5 mmol) and TEA (0.07 ml 0.5 mmol) were dissolved in CH 2 Cl 2 (10 ml), and then a solution of TsCl (95 mg, 0.5 mmol) in CH 2 Cl 2 (5 ml) was added in 0.25-ml aliquots every 10 min while stirring at room temperature. After the addition was complete, the mixture was stirred at room temperature for 2 d, and then the reaction mixture was washed with water and dried over Na 2 SO 4 . Evaporation of the solvent yielded the crude compound as an oil, which was purified by column chromatography on silica gel with CHCl 3 : MeOH : 25% NH4OH (100 : 20 : 2) to give a colorless oil (138 mg, 49% 4,9-Di-tert-butoxycarbonyl-13-(butane-1-sulfonyl)-4,9,13-triazatridecylamime (19) 4,9-Diaza-4,9-di-(tert-butoxycarbonyl)dodecane-1,12-diamine (630 mg, 1.57 mmol) and TEA (0.219 ml, 1.57 mmol) were dissolved in CH 2 Cl 2 (30 ml), and then a solution of BsCl (245 mg, 1.57 mmol) in CH 2 Cl 2 (15 ml) was added in 0.25-ml aliquots every 10 min while stirring at room temperature. After the addition was complete, the mixture was stirred at room temperature for 2 d, then the reaction mixture was washed with water and dried over Na 2 SO 4 . Evaporation of the solvent yielded the crude compound as an oil, which was purified by column chromatography on silica gel with CHCl 3 : MeOH : 25% NH 4 
